Genetic Basis of Inter- and Intrastrain Differences in Diazepam p-Hydroxylation in Rats

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Drug Metabolism And Disposition

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/dmd.108.024273PMID 18971314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IMPORTANCE OF CYP2D3 IN POLYMORPHISM OF DIAZEPAM P-HYDROXYLATION IN RATS

  2005cited by this paper
• Strain differences in diazepam metabolism at its three metabolic sites in sprague-dawley, brown norway, dark agouti, and wistar strain rats.

  2004cited by this paper
• Polymorphism in diazepam metabolism in Wistar rats.

  2004cited by this paper
• Colourful history of Japan's rat resources

  2004cited by this paper
• Phylogenetics of rat inbred strains

  2003cited by this paper
• A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam

  2002cited by this paper
• Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety.

  2001cited by this paper
• Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice

  2000cited by this paper
• Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2.

  1998cited by this paper
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

  1996cited by this paper
• Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

  1994cited by this paper
• Pharmacokinetic differences of desmethyldiazepam in three outbred Wistar strains related to differences in liver enzyme activities.

  1993cited by this paper
• The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects.

  1990cited by this paper
• Metabolism of diazepam in vitro by human liver. Independent variability of N-demethylation and C3-hydroxylation.

  1988cited by this paper
• The molecular biology of cytochrome P450s.

  1988cited by this paper

• Interindividual Variations in Metabolism and Pharmacokinetics of 3-(6-Methylpyridine-3-yl-sulfanyl)-6-(4H-[1,2,4]triazole-3-yl-sulfanyl)-N-(1,3-thiazole-2-yl)-2-pyridine carboxamide, a Glucokinase Activator, in Rats Caused by the Genetic Polymorphism of CYP2D1

  2014cites this paper
• Analysis of energy expenditure in diet-induced obese rats.

  2014cites this paper
• Effect of Use Two General Anesthetic Regimes on Some Clinical and Biochemical Parameters in Donkeys

  2012cites this paper
• Comparative and veterinary pharmacogenomics.

  2010cites this paper
• Intrastrain differences in seizure susceptibility, pharmacological response and basal neurochemistry of Wistar rats.

  2009cites this paper
• Drug Discovery and Development Tomorrow — Changing the Mindset

  2009cites this paper
• Impact of rat P450 genetic polymorphism on diazepam metabolism

  2009cites this paper